1 / 6

Africa IVD Market by Product & Solution, Technology

The Africa IVD Market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030. In vitro diagnostics (IVD) are tests performed on samples of blood or tissue taken from the human body to detect a wide range of diseases. These tests are used for preventing and treating various diseases. IVD test kits are generally used by hospital labs, private labs, government bodies, long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories to detect a wide range of diseases. The Africa IVD market covers various IVD tests based on te

richas
Télécharger la présentation

Africa IVD Market by Product & Solution, Technology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Africa IVD Market to be Worth $1.49 Billion by 2030

  2. Africa IVD Market to be worth $1.49 Billion by 2030 The Africa IVD Market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030. In vitro diagnostics (IVD) are tests performed on samples of blood or tissue taken from the human body to detect a wide range of diseases. These tests are used for preventing and treating various diseases. IVD test kits are generally used by hospital labs, private labs, government bodies, long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories to detect a wide range of diseases. The Africa IVD market covers various IVD tests based on technologies such as immunoassay, whole blood glucose monitoring, molecular diagnostics, point of care, clinical chemistry, hematology, coagulation & hemostasis, critical care, and urinalysis. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/africa-ivd-market-5415 The Africa IVD market is segmented based on Product Category (Reagents, & Kits, Instruments, and Software & Services), Technology (Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Microbiology, Coagulation & Hemostasis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, Point-of-care Testing, and OTC/Self-testing), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Healthcare, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market shares. Download Sample Report Here: https://www.meticulousresearch.com/download-sample- report/cp_id=5415 Reagents & Kits Generated the Larger Proportion of Revenue Compared to Instruments, Software & Services In 2023, the reagents & kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the frequent use of assays & kits in the detection of various chronic diseases, the commercial availability of a diverse range of reagents & consumables for the diagnosis of various diseases, and the increase in the volume of testing for the infectious diseases, such as COVID-19 and influenza Based on Technology, in 2023, the Molecular Diagnostics Segment Dominated the Market In 2023, the molecular diagnostics segment is expected to account for the largest share of the Africa IVD market. The high prevalence of infectious diseases and rising penetration of advanced molecular techniques are expected to fuel market growth. Based on Diagnostic Approach, in 2023, the Lab Testing Segment Registered Largest Share in the Africa IVD Market In 2023, the lab testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy of laboratory testing. Page 1 of 5 © Meticulous Research| sales@meticulousresearch.com

  3. Africa IVD Market to be worth $1.49 Billion by 2030 Based on Application, 2023, the Infectious Diseases Segment Registered Largest Share in the Africa IVD Market In 2023, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region, the increased awareness about diagnostic testing, and the wide availability of COVID-19 test kits across the region. Based on End User, in 2023, the Hospitals & Clinics Segment Generated the Largest Proportion of Revenue In 2023, the hospitals & clinics segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the rising initiatives to support diagnostic testing in hospitals. Request for Report:https://www.meticulousresearch.com/request-sample-report/cp_id=5415 Geographic Review This research report analyzes the market across major African countries and provides a comprehensive analysis of South Africa, Algeria, Nigeria, Kenya, Morocco, Tunisia, Tanzania, Egypt, and the rest of Africa. Key Players Key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG Page 2 of 5 © Meticulous Research| sales@meticulousresearch.com

  4. Africa IVD Market to be worth $1.49 Billion by 2030 (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China). Customize Report:https://www.meticulousresearch.com/request-customization/cp_id=5415 Scope of the Report Africa IVD Market Assessment, by Product Category •Reagents & Kits •Instruments •Software & Services Africa IVD MarketAssessment, by Technology •Molecular Diagnostics •Point-of-care Diagnostics •Immunoassay/Immunochemistry •Biochemistry/Clinical Chemistry •Whole Blood Glucose Monitoring •Hematology •Microbiology •Coagulation & Hemostasis •Other IVD Technologies (Note: Other technologies include urinalysis, hybridization, and loop-mediated amplification.) Africa IVD MarketAssessment, by Application •Infectious Diseases •Oncology •Diabetes •Cardiology •Nephrology •Autoimmune Disorders •Other Applications (Note: Other applications include toxicology, gastroenterology, neonatal, genetic, and neurological disorders.) Africa IVD MarketAssessment, by Diagnostic Approach •Lab Testing •Point-of-care Testing •OTC/Self-testing Page 3 of 5 © Meticulous Research| sales@meticulousresearch.com

  5. Africa IVD Market to be worth $1.49 Billion by 2030 Africa IVD MarketAssessment, by End User •Hospitals & Clinics •Diagnostic Laboratories •Home Care •Other End Users (Note: Other end users include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.) Africa IVD MarketAssessment, by Country •South Africa •Egypt •Algeria •Nigeria •Morocco •Kenya •Tunisia •Tanzania •Rest of Africa Buy Now:https://www.meticulousresearch.com/Checkout/47708335 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 4 of 5 © Meticulous Research| sales@meticulousresearch.com

  6. Africa IVD Market to be worth $1.49 Billion by 2030 Page 5 of 5 © Meticulous Research| sales@meticulousresearch.com

More Related